Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF778 divergent transcript (ZNF778-DT)
- Target
- ZNF778-DT
- Molecular classification
- Long non-coding RNA
01
Overview
ZNF778 divergent transcript (ZNF778-DT) is a long non-coding RNA (lncRNA) transcribed at the ZNF778 locus, also known as RP5-821D11.7. The specific molecular and biological function of ZNF778-DT has not been characterized. As a divergent non-coding transcript near a zinc finger protein-encoding gene (ZNF778), it may play a regulatory role in transcription or chromatin states. However, there is no definitive evidence establishing it as a therapeutic target, nor links to disease or clinical drug interactions at present. ZNF778-DT is an RNA transcript overlapping/diverging from the ZNF778 locus, but should not be confused with the protein-coding ZNF778 gene itself, which is a KRAB-domain C2H2-type zinc finger transcription factor implicated in neural development and cognitive disorders. Data on biological function, disease relevance, or clinical utility of ZNF778-DT is currently insufficient, and it is not considered a classical therapeutic target.
- Other names
- RP5-821D11.7ZNF778-DT
02
Biological functions
No well-characterized biological function established; likely related to transcriptional regulation in proximity to ZNF778 but insufficient direct evidence
03
Disease associations
No disease associations or roles as a direct causal agent currently reported for ZNF778-DT; any disease links would derive from its relationship to the ZNF778 locus
Beyond the preview
Go deeper on ZNF778 divergent transcript (ZNF778-DT).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ZNF778 divergent transcript (ZNF778-DT).